Discover trends, market shifts, and competitive outlooks for the autoimmune disease diagnosis industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has The Autoimmune Disease Diagnosis Market Size Shifted, And What Is the Outlook Through 2034?

The market size for diagnosing autoimmune diseases has significantly expanded in recent years. It is projected to escalate from $5.84 billion in 2024 to $6.25 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. Factors such as a heightened number of autoimmune diseases, the expansion of emerging markets, a surge in healthcare spending, and a higher occurrence in women have contributed to the growth during the historic period.

Expectations indicate a robust expansion in the autoimmune disease diagnosis market size in the coming years. The market is forecasted to escalate to $8.81 billion in 2029 with a compound annual growth rate (CAGR) of 9.0%. The predicted growth during the forecast period can be linked to the rise in funding for autoimmune (ai) diagnostics, accelerated economic growth, increased understanding of autoimmune diseases, and the discovery of biomarkers. Predominantly, the forecast period will see collaborations with other industry participants, investments in artificial intelligence firms, partnerships with the government, and the development of rapid at-home test kits.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3231&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Autoimmune Disease Diagnosis Market?

The expansion of the autoimmune disease diagnosis market can be attributed to a notable rise in autoimmune diseases. To illustrate, Multiple Sclerosis Australia, an Australian national non-profit organization focused on research and advocacy for sufferers of multiple sclerosis, reported in February 2023 that the number of Multiple Sclerosis patients in Australia was 33,335 in 2021. This signifies a surge of 30% (7,728) compared to the previous four year period (25,607). Consequently, the escalating prevalence of autoimmune diseases worldwide is fuelling the growth of the autoimmune disease diagnosis market.

Which Primary Segments of the Autoimmune Disease Diagnosis Market Are Driving Growth and Industry Transformations?

The autoimmune disease diagnosis market covered in this report is segmented –

1) By Product: Consumables And Assay Kits, Instruments

2) By End User: Clinical Laboratories, Hospitals, Others

3) By Test Type: Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests

Subsegments:

1) By Consumables And Assay Kits: ELISA Kits, Reagents And Test Kits, Sample Collection And Preservation Devices, Control And Calibration Materials

2) By Instruments: Immunoassay Analyzers, Flow Cytometers, Luminometers, Microscopes, Other Diagnostic Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3231&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Autoimmune Disease Diagnosis Market?# Market?

North America was the largest region in the autoimmune disease diagnosis market in 2024. Western Europe was the second largest region in the autoimmune disease diagnosis market share. The regions covered in the autoimmune disease diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Most Significant Market Trends in the Autoimmune Disease Diagnosis Market?

The autoimmune disease diagnosis market is experiencing advancement with the introduction of biosensors and nano biosensors which are innovative tools for swift detection. They are popular due to their low expense, high sensitivity, simplicity in use, multiplexing capabilities, and speedy diagnostics. These tools not only accurately measure the volume of antibodies in human blood serum, but also evaluate the activity of those antibodies using portable optical label-free biosensors, based on spectral correlation interferometry. Compared to traditional methods, this point-of-care technology provides a more comprehensive, precise and quick diagnosis of autoimmune diseases.

View the full report here:

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

What Parameters Are Used to Define the Autoimmune Disease Diagnosis Market?

Autoimmune disease diagnosis refers to the diagnosis of diseases in which the production of antibodies takes place in the body which attacks and destroys healthy cells in the body. These include Crohn’s disease, rheumatoid arthritis, Hashimoto’s disease, multiple sclerosis, Grave’s disease, psoriasis, coeliac disease, type 1 diabetes, lupus, and inflammatory bowel syndrome, and are diagnosed by immunological tests.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3231

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model